Natural Grocers by Vitamin Cottage
NGVC
30.41
+0.37
+1.22%
Natural Grocers by Vitamin Cottage
US · NGVC
#3523 by market cap
30.41
+0.37
+1.22%
Live - 5344 symbols - heartbeat 434s ago
· 2026-10-08 10:03
After-hours
30.04
0.00%
- Market cap
- 700.71M
- P/E (TTM)i
- 14.83
- P/Bi
- 2.93
- EPSi
- 2.00
- Div yieldi
- 1.87%
- 52W posi
- 43%
Reader sentiment
Are you bullish or bearish on NGVC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.54, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +7.19% YoY
Margins
- Gross margin
- 29.90%
- Operating margin
- 4.74%
- Net margin
- 3.49%
Key ratios & quality
- PEG ratioi
- 0.50
- Altman Z-Scorei
- 3.54
PEG uses trailing P/E against the 3-year net income growth rate (29.54%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 849.04M | 903.58M | 1.04B | 1.06B | 1.09B | 1.14B | 1.24B | 1.33B |
| Gross profit | 225.57M | 238.75M | 283.14M | 292.19M | 304.88M | 326.93M | 364.81M | 397.88M |
| Selling & admin expenses | 21.51M | 22.84M | 26.78M | 28.36M | 31.56M | 34.37M | 37.05M | 41.43M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 17.33M | 18.12M | 29.29M | 29.25M | 31.26M | 33.68M | 48.70M | 63.03M |
| Pretax profit | 10.49M | 11.81M | 25.70M | 26.06M | 27.78M | 28.37M | 42.80M | 58.93M |
| Tax | -2.17M | 2.40M | 5.69M | 5.48M | 6.42M | 5.13M | 8.87M | 12.48M |
| Net profit | 12.66M | 9.42M | 20.01M | 20.58M | 21.37M | 23.24M | 33.94M | 46.44M |
| Basic EPS | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 2 |
| Diluted EPS | 0.56 | 0.42 | 0.89 | 0.91 | 0.94 | 1.02 | 1.47 | 2.00 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 335.77M | 328.71M | 336.14M | 335.58M | 337.38M | 334.74M |
| Gross profit | 101.75M | 98.28M | 99.03M | 98.86M | 102.44M | 98.01M |
| Selling & admin expenses | 11.02M | 10.95M | 7.94M | 10.84M | 12.13M | 9.50M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 17.97M | 15.61M | 15.67M | 15.02M | 18.75M | 16.28M |
| Pretax profit | 16.80M | 14.89M | 14.81M | 13.93M | 17.47M | 14.33M |
| Tax | 3.70M | 3.29M | 3.01M | 2.60M | 4.04M | 3.26M |
| Net profit | 13.10M | 11.61M | 11.80M | 11.33M | 13.43M | 11.07M |
| Basic EPS | 1 | 1 | 1 | 0 | 1 | 0 |
| Diluted EPS | 0.56 | 0.50 | 0.51 | 0.49 | 0.58 | 0.48 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 110.95M | 115.18M | 143.41M | 135.63M | 140.66M | 152.55M | 147.06M | 168.08M |
| Cash & ST investments | 9.40M | 6.21M | 28.53M | 23.68M | 12.04M | 18.34M | 8.87M | 17.12M |
| Inventory | 94.23M | 96.18M | 100.18M | 100.55M | 113.76M | 119.26M | 120.67M | 132.97M |
| Total assets | 307.08M | 327.11M | 681.79M | 655.08M | 663.11M | 669.19M | 655.48M | 670.50M |
| Total current liabilities | 79.69M | 83.27M | 129.15M | 133.77M | 137.73M | 154.03M | 164.13M | 158.78M |
| Short-term debt | 736.00K | 1.05M | 34.99M | 38.23M | 39.71M | 40.29M | 39.89M | 40.56M |
| Long-term debt | 13.19M | 5.69M | -- | 21.94M | 13.94M | 5.94M | -- | -- |
| Total liabilities | 160,357,000.00 | 170,208,000.00 | 508,726,000.00 | 512,348,000.00 | 507,296,000.00 | 498,344,000.00 | 481,222,000.00 | 458,109,000.00 |
| Total equity | 146.73M | 156.91M | 173.07M | 142.73M | 155.81M | 170.84M | 174.25M | 212.40M |
| Retained earnings | 91.51M | 100.92M | 116.29M | 85.42M | 97.72M | 111.87M | 113.90M | 149.34M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 163.25M | 156.98M | 168.08M | 166.81M | 170.56M | 174.12M |
| Cash & ST investments | 21.21M | 13.18M | 17.12M | 23.21M | 20.72M | 17.47M |
| Inventory | 124.77M | 124.63M | 132.97M | 127.89M | 129.69M | 135.29M |
| Total assets | 664.59M | 659.00M | 670.50M | 668.56M | 684.70M | 687.69M |
| Total current liabilities | 167.72M | 154.49M | 158.78M | 156.39M | 162.48M | 158.23M |
| Short-term debt | 40.34M | 40.56M | 40.56M | 40.70M | 41.49M | 42.04M |
| Long-term debt | -- | -- | -- | -- | 1.45M | 1.39M |
| Total liabilities | 471,615,000.00 | 456,496,000.00 | 458,109,000.00 | 448,545,000.00 | 453,806,000.00 | 448,271,000.00 |
| Total equity | 192.98M | 202.50M | 212.40M | 220.01M | 230.90M | 239.42M |
| Retained earnings | 131.44M | 140.29M | 149.34M | 157.22M | 167.20M | 174.81M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 42.86M | 37.38M | 66.50M | 53.88M | 39.69M | 64.61M | 73.76M | 55.30M |
| Depreciation & amortization | 29.43M | 28.98M | 31.19M | 29.63M | 27.91M | 28.91M | 30.93M | 31.81M |
| Free cash flow | 19.15M | 4.65M | 36.92M | 25.59M | 8.25M | 26.51M | 35.08M | 23.93M |
| Dividends paid | 0 | 0 | -6.30M | -51.45M | -9.07M | -9.09M | -31.87M | -11.01M |
| Stock buybacks / issuance | -581.00K | -- | -- | 0 | 0 | -181.00K | 0 | 0 |
| Ending cash balance | 9.40M | 6.21M | 28.53M | 23.68M | 12.04M | 18.34M | 8.87M | 17.12M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 34.06M | 2.93M | 15.63M | 21.13M | 22.71M | 11.26M |
| Depreciation & amortization | 7.89M | 7.95M | 8.02M | 7.97M | 8.15M | 8.33M |
| Free cash flow | 27.55M | -4.17M | 7.54M | 11.53M | 1.92M | 1.24M |
| Dividends paid | -2.75M | -2.76M | -2.75M | -3.46M | -3.46M | -3.46M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 21.21M | 13.18M | 17.12M | 23.21M | 20.72M | 17.47M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 9.02 | 6.20 | 12.13 | 13.03 | 14.31 | 14.23 | 19.67 | 24.02 |
| ROA %i | 4.17 | 2.97 | 3.97 | 3.08 | 3.24 | 3.49 | 5.12 | 7.01 |
| ROIC %i | 8.06 | 6.42 | 5.48 | 4.00 | 4.24 | 4.76 | 7.02 | 9.17 |
| 5-year avg ROE %i | 10.72 | 9.02 | 8.42 | 9.14 | 10.94 | 11.98 | 14.67 | 17.05 |
| EBIT margin %i | 1.77 | 1.86 | 2.68 | 2.68 | 2.77 | 2.78 | 3.78 | 4.66 |
| FCF / sales %i | 2.26 | 0.51 | 3.56 | 2.42 | 0.76 | 2.32 | 2.83 | 1.80 |
| Current ratioi | 1.39 | 1.38 | 1.11 | 1.01 | 1.02 | 0.99 | 0.90 | 1.06 |
| Quick ratioi | 0.18 | 0.14 | 0.29 | 0.24 | 0.16 | 0.19 | 0.13 | 0.18 |
| Debt / assetsi | 17.69 | 17.80 | 58.69 | 61.29 | 59.32 | 55.32 | 52.86 | 49.52 |
| LT debt / equityi | 36.53 | 36.43 | 210.99 | 254.52 | 226.98 | 193.10 | 175.96 | 137.23 |
| Interest coveragei | 3.30 | 3.39 | 13.55 | 12.47 | 12.72 | 9.60 | 11.25 | 20.24 |
| Revenue CAGR (3Y) %i | 10.77 | 8.60 | 10.47 | 7.53 | 6.44 | 3.23 | 5.56 | 6.89 |
| Net income CAGR (3Y) %i | -7.90 | -6.37 | 42.66 | 17.58 | 31.41 | 5.12 | 18.14 | 29.54 |
| FCF CAGR (3Y) %i | 65.12 | -- | -- | 10.16 | 21.06 | -10.45 | 11.08 | 42.61 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 23.38 | 23.58 | 24.02 | 23.81 | 22.73 | 21.56 |
| ROA %i | 6.25 | 6.65 | 7.01 | 7.26 | 7.14 | 7.08 |
| ROIC %i | 8.38 | 8.67 | 9.17 | 9.33 | 9.29 | 9.06 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.30 | 4.44 | 4.66 | 4.74 | 4.77 | 4.71 |
| FCF / sales %i | 3.19 | 2.58 | 1.80 | 3.18 | 1.26 | 1.66 |
| Current ratioi | 0.97 | 1.02 | 1.06 | 1.07 | 1.05 | 1.10 |
| Quick ratioi | 0.20 | 0.17 | 0.18 | 0.21 | 0.21 | 0.18 |
| Debt / assetsi | 50.49 | 50.76 | 49.52 | 48.60 | 47.40 | 46.92 |
| LT debt / equityi | 152.98 | 145.17 | 137.23 | 129.20 | 122.58 | 117.22 |
| Interest coveragei | 14.77 | 17.12 | 20.24 | 22.18 | 23.34 | 23.39 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Grocery is the largest reported line at 72.89% of revenue, across 3 reported segments.
- The next-largest line, Dietary supplements, is a distant second at 17.88% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Grocery72.89%
Dietary supplements17.88%
Body care, pet care and other9.23%
Quote time 2026-10-08 10:03:59 · For reference only, not investment advice and not tailored to your situation.